SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001214659-23-004102
Filing Date
2023-03-22
Accepted
2023-03-22 16:30:37
Documents
14
Period of Report
2023-03-22
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 r3212308k.htm   iXBRL 8-K 26286
2 EXHIBIT 99.1 ex99_1.htm EX-99.1 9299
3 GRAPHIC alzamendlogo_med.jpg GRAPHIC 24066
  Complete submission text file 0001214659-23-004102.txt   249608

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE alzn-20230322.xsd EX-101.SCH 2935
5 XBRL LABEL FILE alzn-20230322_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE alzn-20230322_pre.xml EX-101.PRE 22343
8 EXTRACTED XBRL INSTANCE DOCUMENT r3212308k_htm.xml XML 3826
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

IRS No.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: 8-K | Act: 34 | File No.: 001-40483 | Film No.: 23753305
SIC: 2834 Pharmaceutical Preparations